Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference GlobeNewswire November 18, 2025 JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will […]